Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avinger Inc (NQ: AVGR )

0.7744 -0.0056 (-0.72%)
Streaming Delayed Price Updated: 9:37 AM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avinger Inc

< Previous 1 2 3 Next >
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
Via ACCESSWIRE
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
Via ACCESSWIRE
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
Via ACCESSWIRE
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
Via ACCESSWIRE
Avinger Reports Second Quarter 2024 Results
Via ACCESSWIRE
Avinger Announces Closing of up to $24 Million Public Offering
Via ACCESSWIRE
Avinger Announces Pricing of up to $24 Million Public Offering
Via ACCESSWIRE
Avinger Reports First Quarter 2024 Results
Via ACCESSWIRE
Avinger Reports Fourth Quarter and Full Year 2023 Results
Via ACCESSWIRE
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
Via ACCESSWIRE
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
Via ACCESSWIRE
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
Via ACCESSWIRE
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
Via ACCESSWIRE
Avinger to Announce First Quarter 2024 Results on May 15, 2024
Via ACCESSWIRE
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
Via ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
Avinger Raises $5.3 Million via At-The-Market Facility
Via ACCESSWIRE
Avinger to Announce Full Year 2023 Results on March 20, 2024
Via ACCESSWIRE
Avinger Reports Third Quarter 2023 Results
Via ACCESSWIRE
Avinger to Announce Third Quarter 2023 Results on October 26
Via ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Near the Top of Equities by Percentage Gain on 9/19
Via Investor Brand Network
Avinger Inc. (NASDAQ: AVGR) Near Top of Volume Charts in Monday Trading
Via Investor Brand Network
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
Via ACCESSWIRE
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
Via ACCESSWIRE
Avinger to Announce Second Quarter 2023 Results on July 27
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
Via ACCESSWIRE
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
Via ACCESSWIRE
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Via ACCESSWIRE
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.